{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:28:18Z","timestamp":1786994898158,"version":"build-2736575974"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.neuropharm.2018.07.021","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T23:01:44Z","timestamp":1533942104000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (A\u03b2) species on long-term potentiation (LTP)"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1698-4257","authenticated-orcid":false,"given":"Gerhard","family":"Rammes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Seeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korinna","family":"Mattusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1868-5082","authenticated-orcid":false,"given":"Kaichuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-2918","authenticated-orcid":false,"given":"Markus","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Herms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris G.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.07.021_bib1","series-title":"Memantine Reverses SS-amyloid Oligomers-induced Deficits in Long Term Potentiation (LTP) in Murine Hippocampal Slices","author":"Albrecht","year":"2008"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib2","series-title":"Alzheimer's & Dementia. 13th International Conference on Alzheimer's Disease (ICAD), Vienna, Austria","first-page":"1847","article-title":"Memantine reverses \u00df-amyloid oligomers-induced deficits in long term potentiation (LTP) in murine hippocampal slices","author":"Albrecht","year":"2009"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib3","first-page":"177","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"30","author":"Alzheimer","year":"1907","journal-title":"Centralblatt fur Nervenheilkunde Psychiatrie"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib4","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0511065103","article-title":"NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation","volume":"103","author":"Amadoro","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"108","author":"Anderson","year":"2001","journal-title":"J.\u00a0Neurosci. Meth."},{"issue":"825","key":"10.1016\/j.neuropharm.2018.07.021_bib6","article-title":"Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity","volume":"33","author":"Bao","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","article-title":"Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease","volume":"95","author":"Barghorn","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib8","first-page":"11","article-title":"Altered synaptic function in Alzheimer's disease","volume":"545","author":"Bell","year":"2006","journal-title":"Eur. J. Pharmacol., Mol. Pharmacol. Sect."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000116984","article-title":"Staging of Alzheimer-related cortical destruction","volume":"33","author":"Braak","year":"1993","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1460-9568.2007.05431.x","article-title":"Maintenance of superior learning and memory function in NR2B transgenic mice during ageing","volume":"25","author":"Cao","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbr.2011.08.024","article-title":"Behavioural and cellular effects of exogenous amyloid-beta peptides in rodents","volume":"225","author":"Chambon","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib12","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1046\/j.1471-4159.1997.69052138.x","article-title":"Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: direct demonstration of NMDA receptors comprising NR1, NR2A, and NR2B subunits within the same complex","volume":"69","author":"Chazot","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer's disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3940(89)90038-4","article-title":"Low-frequence activation of the NMDA receptor system can prevent the induction of LTP","volume":"105","author":"Coan","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib15","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.bbapap.2006.08.003","article-title":"Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells","volume":"1764","author":"Cynis","year":"2006","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib16","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/gps.938","article-title":"The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease preclinical evidence","volume":"18","author":"Danysz","year":"2003","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib18","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease","volume":"285","author":"Demuro","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib2a","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0166-2236(94)90130-9","article-title":"Infrared videomicroscopy: a new look at neuronal structure and function","volume":"17","author":"Dodt","year":"1994","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-60761-744-0_11","article-title":"Abeta toxicity in primary cultured neurons","volume":"670","author":"Ferreira","year":"2011","journal-title":"Meth. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","article-title":"The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease","volume":"96","author":"Ferreira","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib22","doi-asserted-by":"crossref","first-page":"8501693","DOI":"10.1155\/2016\/8501693","article-title":"Current research therapeutic strategies for Alzheimer's disease treatment","volume":"2016","author":"Folch","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0028-3908(99)00060-X","article-title":"Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices","volume":"38","author":"Frankiewicz","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1476-5381.1996.tb15245.x","article-title":"Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices","volume":"117","author":"Frankiewicz","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajpath.2013.05.005","article-title":"Pyroglutamate-3 amyloid-beta deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models","volume":"183","author":"Frost","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib26","doi-asserted-by":"crossref","first-page":"20130136","DOI":"10.1098\/rstb.2013.0136","article-title":"Expression mechanisms underlying long-term potentiation: a postsynaptic view, 10 years on","volume":"369","author":"Granger","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib27","doi-asserted-by":"crossref","first-page":"3204519","DOI":"10.1155\/2016\/3204519","article-title":"Amyloid-beta-Induced dysregulation of AMPA receptor trafficking","volume":"2016","author":"Guntupalli","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1471-4159.1996.67010277.x","article-title":"Amyloid beta peptide (25-35) inhibits na+-dependent glutamate uptake in rat hippocampal astrocyte cultures","volume":"67","author":"Harris","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1099-1077(199912)14:8<525::AID-HUP140>3.0.CO;2-T","article-title":"A\u00a0unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes","volume":"14","author":"Heininger","year":"1999","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.021_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-005-2203-9","article-title":"Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat","volume":"179","author":"Higgins","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijdevneu.2014.05.008","article-title":"Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC","volume":"36","author":"Hofling","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib34","doi-asserted-by":"crossref","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","article-title":"Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease","volume":"286","author":"Jawhar","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fnmol.2017.00446","article-title":"AMPA receptor trafficking in natural and pathological aging","volume":"10","author":"Jurado","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neurobiolaging.2009.04.005","article-title":"Protection against Abeta-mediated rapid disruption of synaptic plasticity and memory by memantine","volume":"32","author":"Klyubin","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt258","article-title":"Truncated and modified amyloid-beta species","volume":"6","author":"Kummer","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.neuron.2011.07.001","article-title":"Nitration of tyrosine 10 critically enhances amyloid beta aggregation and plaque formation","volume":"71","author":"Kummer","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib39","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib41","series-title":"38th Society for Neuroscience Annual Meeting, Washington, USA","article-title":"Single molecule trafficking reveals a new mechanism to explain Abeta oligomer (ADDLs) targeting of synapses and interference with memory-related protein distribution","author":"Lacor","year":"2008"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cbpa.2014.10.026","article-title":"Protein amino-terminal modifications and proteomic approaches for N-terminal profiling","volume":"24","author":"Lai","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A\u00a0specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib44","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182743","article-title":"Computational investigation of Amyloid-beta-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer's disease","volume":"12","author":"Liang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib46","doi-asserted-by":"crossref","first-page":"43915","DOI":"10.1038\/srep43915","article-title":"Genetically-directed sparse neuronal labeling in BAC transgenic mice through mononucleotide repeat frameshift","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib47","doi-asserted-by":"crossref","first-page":"20130135","DOI":"10.1098\/rstb.2013.0135","article-title":"The expression of long-term potentiation: reconciling the preists and the positivists","volume":"369","author":"MacDougall","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice","volume":"176","author":"Martinez-Coria","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib49","doi-asserted-by":"crossref","first-page":"12548","DOI":"10.1074\/jbc.273.20.12548","article-title":"Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis","volume":"273","author":"Masliah","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0166-2236(93)90009-B","article-title":"\u00df-amyloid precursor protein metabolites and loss of neuronal ca2+ homeostasis in Alzheimer's disease","volume":"16","author":"Mattson","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-8993(93)90295-X","article-title":"Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF","volume":"621","author":"Mattson","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib52","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1476-5381.2009.00304.x","article-title":"Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential","volume":"157","author":"Mony","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14640748608401615","article-title":"The memory deficits in Alzheimer-type dementia: a review","volume":"38","author":"Morris","year":"1986","journal-title":"Q.\u00a0J. Exp. Psychol."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2018.07.021_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2013.08.013","article-title":"Dysfunctional synapse in Alzheimer's disease - a focus on NMDA receptors","volume":"76","author":"Mota","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib55","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0306-4522(99)00036-6","article-title":"Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide","volume":"92","author":"Noda","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib3a","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib4a","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","article-title":"Amyloid beta peptides and glutamatergic synaptic dysregulation","volume":"210","author":"Parameshwaran","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib56","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1073\/pnas.1307301110","article-title":"Cranial irradiation compromises neuronal architecture in the hippocampus","volume":"110","author":"Parihar","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist\u2013a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib59","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib1a","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-0270(01)00385-5","article-title":"The use of control theory for the design of voltage clamp systems: a simple and standardized procedure for evaluating system parameters","volume":"109","author":"Polder","year":"2001","journal-title":"J.\u00a0Neurosci. Meth."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib60","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157015908783769671","article-title":"Pharmacodynamics of memantine: an update","volume":"6","author":"Rammes","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuropharm.2014.12.037","article-title":"MRZ-99030-A novel modulator of Abeta aggregation: II - reversal of Abeta oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice","volume":"92","author":"Rammes","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib63","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.neuropharm.2011.01.051","article-title":"Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of beta-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices","volume":"60","author":"Rammes","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib64","series-title":"Society for Neuroscience Abstracts. 43rd Society for Neuroscience Annual Meeting, SanDiego, USA","article-title":"The NMDA receptor antagonist radiprodil reverses the synaptotoxic effects of different amyloid-beta (A\u00df) species on long-term potentiation (LTP)","author":"Rammes","year":"2013"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2017.02.003","article-title":"Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Abeta) in murine models of Alzheimer's disease (AD)","volume":"123","author":"Rammes","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib67","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.neurobiolaging.2010.01.011","article-title":"Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors","volume":"32","author":"Ronicke","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib68","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1046\/j.1471-4159.2002.01107.x","article-title":"Pyroglutamate-modified amyloid beta-peptides\u2013AbetaN3(pE)\u2013strongly affect cultured neuron and astrocyte survival","volume":"82","author":"Russo","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib69","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1021\/bi0612667","article-title":"On the seeding and oligomerization of pGlu-amyloid peptides (in\u00a0vitro)","volume":"45","author":"Schilling","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib70","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nm.1872","article-title":"Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology","volume":"14","author":"Schilling","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib72","doi-asserted-by":"crossref","first-page":"11532","DOI":"10.1523\/JNEUROSCI.1603-16.2016","article-title":"Local and use-dependent effects of beta-amyloid oligomers on NMDA receptor function revealed by optical quantal analysis","volume":"36","author":"Sinnen","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/43432","article-title":"Genetic enhancement of learning and memory in mice","volume":"401","author":"Tang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib5a","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers","volume":"572","author":"Townsend","year":"2006","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease","volume":"9","author":"Tu","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib75","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in\u00a0vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib76","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10571-011-9691-4","article-title":"Abeta oligomer-induced synapse degeneration in Alzheimer's disease","volume":"31","author":"Wilcox","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib77","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/NDT.S7460","article-title":"Brain amyloid beta protein and memory disruption in Alzheimer's disease","volume":"6","author":"Xia","year":"2010","journal-title":"Neuropsychiatry Dis. Treat."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib78","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0896-6273(00)80115-4","article-title":"Mechanisms of neuronal degeneration in Alzheimer's disease","volume":"16","author":"Yankner","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.07.021_bib79","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2008.07.046","article-title":"Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity","volume":"55","author":"Yashiro","year":"2008","journal-title":"Neuropharmacology"},{"issue":"42 Suppl.\u00a0l","key":"10.1016\/j.neuropharm.2018.07.021_bib80","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.3233\/JAD-132621","article-title":"Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets","volume":"3","author":"Zadori","year":"2014","journal-title":"J.\u00a0Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2018.07.021_bib81","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0028-3908(97)00070-1","article-title":"Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP","volume":"36","author":"Zajaczkowski","year":"1997","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T11:42:04Z","timestamp":1535110924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818303897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":86,"alternative-id":["S0028390818303897"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (A\u03b2) species on long-term potentiation (LTP)","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}